Somatic POLE exonuclease domain mutations elicit enhanced intratumoral immune responses in stage II colorectal cancer

by Shaobo Mo, Xiaoji Ma, Yaqi Li, Ting Hou, Han Han-Zhang
Published 2020-07-01

The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients

by Dongjing Cai, Chengping Hu, Li Li, Shichao Deng, Jing Yang, Han Han‐Zhang, Min Li
Published 2020-01-01

Clinicopathologic features and genomic analysis of pulmonary blastomatoid carcinosarcoma

by Jikai Zhao, Chan Xiang, Ruiying Zhao, Ping Guo, Jingjing Zheng, Han Han-Zhang, Keke Yu, Jie Zhang, Yuchen Han
Published 2020-03-01

The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients

by Quan Lin, Haoran Zhang, Huaxin Ding, Jun Qian, Analyn Lizaso, Jing Lin, Han Han-Zhang, Jianxing Xiang, Yuping Li, Hong Zhu
Published 2019-08-01

IBI362 (LY3305677), a weekly-dose GLP-1 and glucagon receptor dual agonist, in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple ascending dose...

by Linong Ji, Hongwei Jiang, Pei An, Huan Deng, Meng Liu, Li Li, Liqi Feng, Baili Song, Han Han-Zhang, Qingyang Ma, Lei Qian
Published 2021-09-01

Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma

by Zhen Zhou, Lei Zhu, Xiaomin Niu, Shengping Shen, Yi Zhao, Jie Zhang, Junyi Ye, Han Han‐Zhang, Junjun Liu, Chenglin Liu, Shun Lu
Published 2019-04-01

Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer

by Weikai Xiao, Guochun Zhang, Bo Chen, Xiaoqing Chen, Lingzhu Wen, Jianguo Lai, Xuerui Li, Min Li, Hao Liu, Jing Liu, Han Han-Zhang, Analyn Lizaso, Ning Liao
Published 2021-04-01

Germline Profiling and Molecular Characterization of Early Onset Metastatic Colorectal Cancer

by Ting Xu, Yinjie Zhang, Jing Zhang, Changsong Qi, Dan Liu, Zhenghang Wang, Yanyan Li, Congcong Ji, Jian Li, Xuan Lin, Ting Hou, Hao Liu, Lu Zhang, Han Han-Zhang, Lin Shen, Xicheng Wang
Published 2020-10-01

FXR1 regulates transcription and is required for growth of human cancer cells with TP53/FXR2 homozygous deletion

by Yichao Fan, Jiao Yue, Mengtao Xiao, Han Han-Zhang, Yao Vickie Wang, Chun Ma, Zhilin Deng, Yingxiang Li, Yanyan Yu, Xinghao Wang, Shen Niu, Youjia Hua, Zhiping Weng, Peter Atadja, En Li, Bin Xiang
Published 2017-08-01

Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling

by Zhihua Guo, Zhanhong Xie, Huifang Shi, Wei Du, Lijun Peng, Wei Han, Feidie Duan, Xin Zhang, Mingyan Chen, Junli Duan, Jing Lin, Xuewei Chen, Analyn Ang Lizaso, Han Han‐Zhang, Jianxing He, Weiqiang Yin
Published 2019-04-01

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non‐small cell lung cancer patients

by Ying Ding, Lihua Zhang, Lingchuan Guo, Chunyan Wu, Jianhua Zhou, Yongchun Zhou, Jie Ma, Xiao Li, Pan Ji, Ming Wang, Weidong Zhu, Chenxi Shi, Sanen Li, Wei Wu, Wei Zhu, Desheng Xiao, Chunyan Fu, Qiuyan He, Rui Sun, Xinru Mao, Analyn Lizaso, Bing Li, Han Han‐Zhang, Zhihong Zhang
Published 2020-01-01

EGFR Thr790Leu as a Potential Resistance Mechanism to First-Generation EGFR Tyrosine Kinase Inhibitor May Respond to Osimertinib in Patients With Lung Adenocarcinoma

by Chan Xiang, PhD, Wei Zhang, PhD, MD, Li-Wen Xiong, MD, Xu-Wei Cai, PhD, MD, Hao-Hua Teng, MD, Rui-Ying Zhao, MD, Zhan-Xian Shang, MD, Han Han-Zhang, PhD, Lu Zhang, PhD, Li Yan, MS, Zhi-Qiu Chen, MS, Yu-Chen Han, PhD, MD
Published 2021-07-01

Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I...

by Yi-Chen Zhang, Zhi-Hong Chen, Xu-Chao Zhang, Chong-Rui Xu, Hong-Hong Yan, Zhi Xie, Shao-Kun Chuai, Jun-Yi Ye, Han Han-Zhang, Zhou Zhang, Xiao-Yan Bai, Jian Su, Bin Gan, Jin-Ji Yang, Wen-Feng Li, Wei Tang, Feng Roger Luo, Xiao Xu, Yi-Long Wu, Qing Zhou
Published 2019-05-01